Target Discovery and Validation Reviews and Protocols

Molecular Profiling of Breast Cancer 111
15. Perou, C. M., Jeffrey, S. S., van de Rijn, M., et al. (1999) Distinctive gene expression
patterns in human mammary epithelial cells and breast cancers. Proc. Natl.
Acad. Sci. USA 96, 9212–9217.
16. Ross, D. T., Scherf, U., Eisen, M. B., et al. (2000) Systematic variation in gene
expression patterns in human cancer cell lines. Nat. Genet. 24, 227–235.
17. Whitfield, M. L., Sherlock, G., Saldanha, A. J., et al. (2002) Identification of
genes periodically expressed in the human cell cycle and their expression in
tumors. Mol. Biol. Cell 13, 1977–2000.
18. Aas, T., Borresen, A. L., Geisler, S., et al. (1996) Specific P53 mutations are associated
with de novo resistance to doxorubicin in breast cancer patients. Nat. Med.
2, 811–814.
19. Geisler, SI., Lonning, P. E., Aas, T., et al. (2001) Influence of TP53 gene alterations
and c-erbB-2 expression on the response to treatment with doxorubicin in
locally advanced breast cancer. Cancer Res. 61, 2505–2512.
20. Geisler, S., Borresen-Dale, A. L., Johnsen, H., et al. (2003) TP53 Gene Mutations
Predict the Response to Neoadjuvant Treatment with 5-Fluorouracil and
Mitomycin in Locally Advanced Breast Cancer. Clin. Cancer Res. 9, 5582–5588.
21. Weigelt, B., Glas, A. M., Wessels, L. F., Witteveen, A. T., Peterse, J. L., and van’t
Veer, L. J. (2003) Gene expression profiles of primary breast tumors maintained
in distant metastases. Proc. Natl. Acad. Sci. USA 100, 15, 901–15, 905.
22. Sorlie, T., Tibshirani, R., Parker, J., et al. (2003) Repeated observation of breast
tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci.
USA 100, 8418–8423.
23. Sorlie, T., Perou, C. M., Tibshirani, R., et al. (2001) Gene expression patterns of
breast carcinomas distinguish tumor subclasses with clinical implications. Proc.
Natl. Acad. Sci. USA 98, 10, 869–10, 874.
24. Bertucci, F., Finetti, P., Rougemont, J., et al. (2005) Gene expression profiling identifies
molecular subtypes of inflammatory breast cancer. Cancer Res. 65, 2170–2178.
25. Chang, H. Y., Nuyten, D. S., Sneddon, J. B., et al. (2005) Robustness, scalability,
and integration of a wound-response gene expression signature in predicting
breast cancer survival. Proc. Natl. Acad. Sci. USA 102, 3738–3743.
26. Sotiriou, C., Neo, S. Y., McShane, L. M., et al. (2003) Breast cancer classification
and prognosis based on gene expression profiles from a population-based study.
Proc. Natl. Acad. Sci. USA 100, 10,393–10,398.
27. Wang, Z. C., Lin, M., Wei, L. J., et al. (2004) Loss of heterozygosity and its correlation
with expression profiles in subclasses of invasive breast cancers. Cancer
Res. 64, 64–71.
28. Yu, K., Lee, C. H., Tan, P. H., and Tan, P. (2004) Conservation of breast cancer
molecular subtypes and transcriptional patterns of tumor progression across distinct
ethnic populations. Clin. Cancer Res. 10, 5508–5517.
29. Zhao, H., Langerod, A., Ji, Y., et al. (2004) Different gene expression patterns in
invasive lobular and ductal carcinomas of the breast. Mol. Biol. Cell 15, 2523–2536.
30. van’t Veer, L. J., Dai, H., van de Vijver, M. J., et al. (2002) Gene expression
profiling predicts clinical outcome of breast cancer. Nature 415, 530–536.